Premium
Highly Enantioselective Hydrogenation of Ethyl 5,5‐Dimethoxy‐3‐oxopentanoate and its Application for the Synthesis of a Statin Precursor
Author(s) -
Korostylev Andrei,
Andrushko Vasyl,
Andrushko Natalia,
Tararov Vitali I.,
König Gerd,
Börner Armin
Publication year - 2008
Publication title -
european journal of organic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 155
eISSN - 1099-0690
pISSN - 1434-193X
DOI - 10.1002/ejoc.200701059
Subject(s) - chemistry , enantioselective synthesis , asymmetric hydrogenation , catalysis , rosuvastatin , alcohol , noyori asymmetric hydrogenation , homogeneous , substrate (aquarium) , homogeneous catalysis , combinatorial chemistry , stereochemistry , medicinal chemistry , organic chemistry , medicine , physics , oceanography , geology , thermodynamics
The highly enantioselective hydrogenation of ethyl 5,5‐dimethoxy‐3‐oxopentanoate ( 3 ) to ethyl 3‐hydroxy‐5,5‐dimethoxypentanoate ( 4 ) – a key intermediate in the synthesis of pharmacologically important statin drugs – has been investigated. The stereochemistry of the catalytic hydrogenation of the β‐keto ester in the presence of a number of homogeneous chiral Rh I and Ru II complexes with phosphane ligands has been studied. The highest enantioselectivity for the homogeneous hydrogenation of 3 (up to 98.7 % ee ) was achieved through an optimized version of Genêt's procedure with a Ru[( R )‐BINAP]Cl 2 pre‐catalyst (substrate/catalyst ratio up to 20 000:1, 50 bar H 2 , 50 °C, in MeOH). The transformation of alcohol R ‐( 4 ) into ylide R ‐( 6 ) as an important precursor of the chiral side chain of rosuvastatin is also illustrated. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)